On Friday, Cedar Realty Trust, Inc. (NYSE:CDR)’s shares surged 5.31% to $7.54, as Cedar Realty will release financial results for the three-month period ended March 31, 2015, after the market closes on Tuesday, May 5, 2015. The Company will host a conference call that same day at 5:00 PM (ET) to talk about the financial results.
Cedar Realty Trust, Inc. is an independent equity real estate investment trust. The firm is primarily engaged in ownership, operation, development, and redevelopment of properties. It invests in the real estate markets of the United States predominantly in mid- Atlantic and Northeast coastal states. The firm primarily invests in supermarket-anchored shopping centers.
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s shares gained 5.18% to $12.19, during the last trading session on Friday, as a biopharmaceutical company, will support several activities surrounding Fabry Disease Awareness Month and International Pompe Day. The Fabry community has designated the month of April to honor and recognize those who are affected by the disease and to promote greater awareness of the disease. The aim of the Second International Pompe Day on April 15 is to foster international awareness of Pompe disease.
In partnership with the Fabry and Pompe communities, Amicus will sponsor and take part in the following events:
Fabry Support and Information Group’s (FSIG) Female Fabry Get Togethers in Minneapolis, MN, on April 11; and Philadelphia, PA on April 18. For more information please contact FSIG at 660-463-1355 or visit www.fabry.org
United Pompe Foundation’s (UPF) Late-Onset Pompe Disease Patient Meeting hosted by the Duke Pompe Disease Clinical and Research Program, Durham, NC, from April 10-11. For more information please visit www.dukechildrens.org/pompe
FSIG’s Fabry Fun Walk/Run in St. Louis, MO, on April 25. For more information please contact FSIG at 660-463-1355 or [email protected]
All-employee Lunch and Learn at Amicus featuring guest speaker Jerry Walter, Founder of the National Fabry Disease Foundation
Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease.
At the end of Friday’s trade, Chipotle Mexican Grill, Inc. (NYSE:CMG)’s shares gained 4.80% to $683.02, as Chipotle Mexican declared that it will host a conference call to talk about first quarter 2015 financial results on Tuesday, April 21, 2015 at 4:30 PM Eastern time. A press release with first quarter 2015 financial results will be issued at about 4:00 PM Eastern time that same day.
The conference call can be accessed live over the phone by dialing 1-888-437-9315 or for international callers by dialing 1-719-325-2418.
Chipotle Mexican Grill, Inc., together with its auxiliaries, develops and operates fast-casual and fresh Mexican food restaurants. As of February 3, 2015, it operated about 1,780 restaurants, counting 17 Chipotle restaurants and 9 ShopHouse Southeast Asian Kitchen restaurants. The company was founded in 1993 and is based in Denver, Colorado.
Finally, Dot Hill Systems Corp. (NASDAQ:HILL), ended its Friday’s trading session with 4.79% gain, and closed at $6.13, hitting its highest level, after Dot Hill declared availability of its new innovative AssuredSAN(R) 6000 Series arrays optimized for key vertical markets counting telecommunications infrastructure, network administration, video surveillance, service providers, high performance computing (HPC) and other Internet of Things (IoT) applications.
The AssuredSAN 6000 Series solution comprises new high performance dual active redundant controllers with 40GB of total system cache, which allows the array to provide up to 12GB/sec of sustained read performance and 5.7GB/sec sustained write-performance. The AssuredSAN 6554 features eight 12Gb SAS ports for host connectivity. Dot Hill AssuredSAN 6000 Series arrays also leverage Dot Hill’s patented RealStream(TM) software technology (see Dot Hill Declares RealStream Software Technology that Dramatically Raises Throughput of Bandwidth-Intensive Applications, also declared recently) to support up to three times the throughput1 for applications involving complex Internet workloads.
The first Dot Hill 6000 Series arrays are accessible with the Ultra56(TM) AssuredSAN ultra-density chassis, which supports up to 1.5 petabytes of capacity using 248 devices with any combination of SSDs and HDDs. In addition, AssuredSAN 6004 models meet both NEBS Level 3 carrier and MIL-STD government requirements. In the telecommunications market segment, NEBS equipment is required to meet carrier grade environmental standards for the highest possible reliability and availability. All AssuredSAN 6004 models deliver Dot Hill’s proven 99.999 percent data availability and feature platinum-rated power supplies.
Dot Hill 6000 Series arrays are now shipping through select OEMs and authorized Dot Hill partners.
Dot Hill will conduct an Analyst Day on April 23, 2015, starting at 9:00 am Eastern Time at the Millennium Broadway Hotel in New York City. This event is open to the public and will provide greater detail about Dot Hill and the industry. In addition to customer and industry analyst insights, Dot Hill administration will talk about the company’s strategy, product positioning and roadmap for hardware platforms and intelligent software capabilities. Executives will also review the company’s financial model, aims and guidance for 2015.
Dot Hill Systems Corp. designs, manufactures, and markets a range of software and hardware storage systems for the entry and mid-range storage markets worldwide. Its storage solutions comprise of integrated hardware, firmware, and software products employing a modular system that allows end-users to add various protocol, performance, capacity, or data protection schemes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
